User menu

Effect of three-drug delivery modalities on Olfactory function in chronic sinusitis

Bibliographic reference Reychler, Gregory ; Colbrant, Coralie ; Huart, Caroline ; Le Guellec, Sandrine ; Vecellio, Laurent ; et. al. Effect of three-drug delivery modalities on Olfactory function in chronic sinusitis. In: The Laryngoscope, Vol. 125, no. 3, p. 549-555 (2014)
Permanent URL
  1. Thomas Mike, Yawn Barbara, Price David, Lund Valerie, Mullol Jocquim, Fokkens Wytske, EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 — a summary, 10.3132/pcrj.2008.00029
  2. Lange B., Holst R., Thilsing T., Baelum J., Kjeldsen A., Quality of life and associated factors in persons with chronic rhinosinusitis in the general population: A prospective questionnaire and clinical cross-sectional study, 10.1111/coa.12189
  3. Stathas, Eur Rev Med Pharmacol Sci, 17, 1455 (2013)
  4. Fokkens, Rhinol Suppl, 1 (2012)
  5. Elsherif H.S., Landis B.N., Hamad M.H., Hugentobler M., Bahig S.M., Gamaa A.M., Lacroix J.S., Olfactory function and nasal nitric oxide : Olfactory function and nNO, 10.1111/j.1749-4486.2007.01534.x
  6. Georgy Mary S., Peters Anju T., Chapter 7: Nasal polyps, 10.2500/aap.2012.33.3537
  7. Sarber Kathleen M., Dion Gregory Robert, Weitzel Erik K., McMains Kevin C., Approaching Chronic Sinusitis : , 10.1097/smj.0000000000000018
  8. Smith Timothy L., Kern Robert, Palmer James N., Schlosser Rodney, Chandra Rakesh K., Chiu Alexander G., Conley David, Mace Jess C., Fu Rongwei F., Stankiewicz James, Medical therapy vs surgery for chronic rhinosinusitis: a prospective, multi-institutional study with 1-year follow-up, 10.1002/alr.21065
  9. Young Lee C., Stow Nicholas W., Zhou Lifeng, Douglas Richard G., Efficacy of medical therapy in treatment of chronic rhinosinusitis, 10.2500/ar.2012.3.0027
  10. Alobid Isam, Mullol Joaquim, Role of Medical Therapy in the Management of Nasal Polyps, 10.1007/s11882-012-0247-6
  11. Ah-See K. L., MacKenzie J., practitioner g., Ah-See K. W., Management of chronic rhinosinusitis, 10.1136/bmj.e7054
  12. Vaidyanathan Sriram, Barnes Martyn, Williamson Peter, Hopkinson Pippa, Donnan Peter T., Lipworth Brian, Treatment of Chronic Rhinosinusitis With Nasal Polyposis With Oral Steroids Followed by Topical Steroids : A Randomized Trial, 10.7326/0003-4819-154-5-201103010-00003
  13. Petty David A., Blaiss Michael S., Intranasal corticosteroids topical characteristics: Side effects, formulation, and volume, 10.2500/ajra.2013.27.3949
  14. Demoly Pascal, Calderon Moises A, Casale Thomas, Scadding Glenis, Annesi-Maesano Isabella, Braun Jean-Jacques, Delaisi Bertrand, Haddad Thierry, Malard Olivier, Trébuchon Florence, Serrano Elie, Assessment of disease control in allergic rhinitis, 10.1186/2045-7022-3-7
  15. Suman Julie D., Laube Beth L., Dalby Richard, 10.1023/a:1011933410898
  16. Vecellio Laurent, De Gersem Ruth, Le Guellec Sandrine, Reychler Gregory, Pitance Laurent, Le Pennec Deborah, Diot Patrice, Chantrel Gilles, Bonfils Pierre, Jamar François, Deposition of aerosols delivered by nasal route with jet and mesh nebulizers, 10.1016/j.ijpharm.2011.01.024
  17. Cheng Yung Sung, Aerosol Deposition in the Extrathoracic Region, 10.1080/02786820300906
  18. Möller Winfried, Schuschnig Uwe, Celik Gülnaz, Münzing Wolfgang, Bartenstein Peter, Häussinger Karl, Kreyling Wolfgang G., Knoch Martin, Canis Martin, Becker Sven, Topical Drug Delivery in Chronic Rhinosinusitis Patients before and after Sinus Surgery Using Pulsating Aerosols, 10.1371/journal.pone.0074991
  19. Durand, Rhinology, 49, 30 (2011)
  20. Hummel T., Kobal G., Gudziol H., Mackay-Sim A., Normative data for the “Sniffin’ Sticks” including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects, 10.1007/s00405-006-0173-0
  21. Heilmann Stefan, Strehle Gundel, Rosenheim Kati, Damm Michael, Hummel Thomas, Clinical Assessment of Retronasal Olfactory Function, 10.1001/archotol.128.4.414
  22. Gudziol Volker, L??tsch J??rn, H??hner Antje, Zahnert Thomas, Hummel Thomas, Clinical Significance of Results from Olfactory Testing : , 10.1097/01.mlg.0000234915.51189.cb
  23. Heilmann, Am J Rhinol, 18, 29 (2004)
  24. Scheibe Mandy, Bethge Christopher, Witt Martin, Hummel Thomas, Intranasal Administration of Drugs, 10.1001/archotol.134.6.643
  25. Lam Kent, Tan Bruce K., Lavin Jennifer M., Meen Eric, Conley David B., Comparison of nasal sprays and irrigations in the delivery of topical agents to the olfactory mucosa : Sprays Versus Irrigations Within Olfactory Cleft, 10.1002/lary.24239
  26. Shu Chih-Hung, Lee Po-Lei, Shiao An-Suey, Chen Kee-Tak, Lan Ming-Ying, Topical corticosteroids applied with a squirt system are more effective than a nasal spray for steroid-dependent olfactory impairment, 10.1002/lary.23212
  27. Goektas Oender, Lau Larissa, Olze Heidi, Treatment of Chronic Rhinosinusitis with Pressure-Pulsed Corticosteroid Inhalation, 10.1007/s12070-013-0625-y
  28. Wang, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 26, 347 (2012)
  29. Rombaux, Rhinology, 47, 28 (2009)
  30. de Monte M., Scruignec J., Dubus J.C., Chaumuzeau J.P., Dautzenberg B., Dessanges J.F., Becquemin M.H., Diot P., N.U.A.G.E.S: A survey of nebulisation practice in France with regard to ERS guidelines, 10.1016/j.rmed.2007.03.004
  31. Durand M., Le Guellec S., Pourchez J., Dubois F., Aubert G., Chantrel G., Vecellio L., Hupin C., De Gersem R., Reychler G., Pitance L., Diot P., Jamar F., Sonic aerosol therapy to target maxillary sinuses, 10.1016/j.anorl.2011.09.002
  32. Newman S. P., Morén F., Clarke S. W., The nasal distribution of metered does inhalers, 10.1017/s0022215100101380
  33. Vidgren, Eur J Drug Metab Pharmacokinet, 3, 426 (1991)
  34. Pires Anaísa, Fortuna Ana, Alves Gilberto, Falcão Amílcar, Intranasal Drug Delivery: How, Why and What for?, 10.18433/j3nc79
  35. Schroeter Jeffry D., Kimbell Julia S., Asgharian Bahman, Analysis of Particle Deposition in the Turbinate and Olfactory Regions Using a Human Nasal Computational Fluid Dynamics Model, 10.1089/jam.2006.19.301
  36. Algorta Jaime, Pena Maria Angeles, Francisco Silvia, Abajo Zurine, Sanz Emilio, Randomised, crossover clinical trial, in healthy volunteers, to compare the systemic availability of two topical intranasal budesonide formulations, 10.1186/1745-6215-9-34
  37. Bacon Rachel, Newman Steve, Rankin Lisa, Pitcairn Gary, Whiting Roger, Pulmonary and nasal deposition of ketorolac tromethamine solution (SPRIX) following intranasal administration, 10.1016/j.ijpharm.2012.04.023
  38. Ryrfeldt, Eur J Respir Dis Suppl, 122, 86 (1982)
  39. Thorsson, Borgå, Edsbäcker, Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder : Systemic availability of budesonide, 10.1046/j.1365-2125.1999.00956.x
  40. Landis Basile N., Giger Roland, Ricchetti Alma, Leuchter Igor, Hugentobler Marianne, Hummel Thomas, Lacroix Jean-Silvain, Retronasal olfactory function in nasal polyposis, 10.1097/00005537-200311000-00026
  41. Pfaar Oliver, Landis Basile Nicolas, Frasnelli Johannes, Hüttenbrink Karl-Bernd, Hummel Thomas, Mechanical Obstruction of the Olfactory Cleft Reveals Differences Between Orthonasal and Retronasal Olfactory Functions, 10.1093/chemse/bjj002
  42. Kendrick A. H., Smith E. C., Wilson R. S., Selecting and using nebuliser equipment, 10.1136/thx.52.2008.s92